Viewing Study NCT06062420

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-05-23 @ 10:07 AM
Study NCT ID: NCT06062420
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-10
First Post: 2023-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms, Head and Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dostarlimab View
None Belrestotug View
None Nelistotug View
None Remzistotug View
None PD-L1 View
None HNSCC View